VVector Bio
BioTech/Drugs - Montreal, Quebec, CA
VVector Bio Employees
VVector Bio Senior Management
VVector Bio Details
VVector Bio is helping biotech companies efficiently manufacture viral vectors for cell and gene therapy and vaccines using proprietary, cutting-edge technologies available for licensing. We have deep expertise in developing scalable processes for viruses used in these therapies and vaccines, including Adeno-associated virus (AAV), lentivirus (LVV), enveloped VLPs, adenovirus, and other virus-like particles such as NDV. Our processes are fully scalable and ready for transfer to a GMP facility. In the context of AAV, we are developing two proprietary manufacturing technologies aimed at improving and simplifying the manufacturing process. Our first technology is a single plasmid system, which optimizes the traditional three-plasmid transfection method, reducing overall costs by 20% and increasing AAV manufacturing yields by 5x. The second technology is a high-producer cell line capable of producing AAV at orders of magnitude higher yields than current industry standards.
VVector Bio Technologies
Load Balancers
Apache
CMS
WordPress.org
Hosted Forms
Gravity Forms
Tag Management
Google Tag Manager
CSS and JavaScript Libraries
Bootstrap Framework
Other
Mobile Friendly